Goldman Sachs Upgrades Amylyx Pharmaceuticals inc. (AMLX) to Buy, 'Expectations for PHOENIX failure appear overdone'
Tweet Send to a Friend
(Updated - July 24, 2023 4:43 AM EDT)
Goldman Sachs analyst Corinne Jenkins upgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Corinne Jenkins upgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
